SEELOS THERAPEUTICS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Seelos Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Seelos Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was -114 %, a 52.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -114 +126 +52.5% Jun 30, 2024
Q1 2024 -119 -4.94K -102% Mar 31, 2024
Q4 2023 -136 -306 -180% Dec 31, 2023
Q3 2023 -159 -240 -298% Sep 30, 2023
Q2 2023 -240 -282 -666% Jun 30, 2023
Q1 2023 4.82K +4.79K +18533% Mar 31, 2023
Q4 2022 170 +145 +591% Dec 31, 2022
Q3 2022 80.5 +54.7 +212% Sep 30, 2022
Q2 2022 42.4 +6.14 +16.9% Jun 30, 2022
Q1 2022 25.9 -76.9 -74.8% Mar 31, 2022
Q4 2021 24.6 -125 -83.6% Dec 31, 2021
Q3 2021 25.8 -228 -89.8% Sep 30, 2021
Q2 2021 36.3 -169 -82.4% Jun 30, 2021
Q1 2021 103 -94.6 -47.9% Mar 31, 2021
Q4 2020 150 -129 -46.3% Dec 31, 2020
Q3 2020 253 +66.8 +35.8% Sep 30, 2020
Q2 2020 206 +9.93K Jun 30, 2020
Q1 2020 197 +431 Mar 31, 2020
Q4 2019 279 +359 Dec 31, 2019
Q3 2019 187 +269 Sep 30, 2019
Q2 2019 -9.72K -10.9K -951% Jun 30, 2019
Q1 2019 -233 -324 -357% Mar 31, 2019
Q4 2018 -80.1 -173 -186% Dec 31, 2018
Q3 2018 -82.3 -428 -124% Sep 30, 2018
Q2 2018 1.14K +1.6K Jun 30, 2018
Q1 2018 90.8 +295 Mar 31, 2018
Q4 2017 93 +288 Dec 31, 2017
Q3 2017 345 +543 Sep 30, 2017
Q2 2017 -457 -258 -129% Jun 30, 2017
Q1 2017 -204 +36.1 +15% Mar 31, 2017
Q4 2016 -195 +154 +44.2% Dec 31, 2016
Q3 2016 -197 +635 +76.3% Sep 30, 2016
Q2 2016 -200 -632 -146% Jun 30, 2016
Q1 2016 -240 Mar 31, 2016
Q4 2015 -349 Dec 31, 2015
Q3 2015 -832 Sep 30, 2015
Q2 2015 432 Jun 30, 2015
Q4 2013 150 +62.6 +71.9% Dec 31, 2013
Q3 2013 186 +105 +129% Sep 30, 2013
Q2 2013 152 +61.4 +67.8% Jun 30, 2013
Q1 2013 138 +30.3 +28.1% Mar 31, 2013
Q4 2012 87.1 Dec 31, 2012
Q3 2012 81.2 Sep 30, 2012
Q2 2012 90.6 Jun 30, 2012
Q1 2012 108 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.